The American College of Rheumatology and the National Psoriasis Foundation have issued evidence-based guidelines for the pharmacologic and nonpharmacologic treatment of active psoriatic arthritis.
Adding abatacept to methotrexate improves disease activity and reduces structural progression among ACPA-positive rheumatoid arthritis patients with early erosion, Japanese researchers report.
Patients with large vessel involvement when diagnosed with biopsy-confirmed giant cell arteritis have a substantially increased risk of death relative to patients with no large vessel involvement, Italian researchers report.
Results of an observational study provide preliminary evidence suggesting that patients with gout and fatty liver disease who are treated with febuxostat do not have an elevated risk for hepatotoxicity.
Findings from the PRAIRI trial suggest that a single infusion of the B-cell directed agent rituximab could delay the development of rheumatoid arthritis among individuals positive for anti-citrullinated peptide antibodies and rheumatoid factor.
Source:
Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2017-212763
Follow medwireNews